4-(Trifluoromethyl)aniline → 1-(3-chloro-2-pyridinyl)-4-hydroxy-N-[4-(trifluoromethyl)phenyl]-4-piperidinecarboxamide
反応式
[Cl:1][C:2]1[C:3]([N:8]2[CH2:13][CH2:12][C:11]([OH:17])([C:14]([OH:16])=O)[CH2:10][CH2:9]2)=[N:4][CH:5]=[CH:6][CH:7]=1.CCN=C=NCCCN(C)C.[F:29][C:30]([F:39])([F:38])[C:31]1[CH:37]=[CH:36][C:34]([NH2:35])=[CH:33][CH:32]=1>ClCCl>[Cl:1][C:2]1[C:3]([N:8]2[CH2:9][CH2:10][C:11]([OH:17])([C:14]([NH:35][C:34]3[CH:36]=[CH:37][C:31]([C:30]([F:29])([F:38])[F:39])=[CH:32][CH:33]=3)=[O:16])[CH2:12][CH2:13]2)=[N:4][CH:5]=[CH:6][CH:7]=1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
1-(3-Chloro-2-pyridinyl)-4-hydroxy-4-piperidinecarboxylic acid, EDCI (525 mg, 2.7 mmol), and 4-(trifluoromethyl)aniline in dichloromethane (10 mL) were combined at room temperature and stirred overnight. Standard work-up gave a crude product which was purified via chromatography (SiO2, ethyl acetate:hexanes, 1:9). 1H NMR (500 MHz, CDCl3) δ 8.90 (s(br), 1H), 8.20 (dd, 1H), 7.74 (d, 2H), 7.61 (m, 3H), 6.86 (dd, 1H), 3.80 (m, 2H), 3.18 (m, 2H), 2.50 (m, 2H), 1.78 (m, 2H); MS (ESI, M+H)+400.
後処理
- customwere combined at room temperature
出典と根拠
- ORDレコード
- ord-2aae64c9b2a248a190593ca137421949
- 出典データセット
- uspto-grants-2006_10
- 特許番号
- US07129235B2
反応ノート
読み込み中…